Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 64
	QLoRA Alpha: 64.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: The present study suggests that BF% is a good predictor of neonatal morbidity, as it is more strongly associated with such morbidity than birth weight percentiles. Therefore, BF% may be considered a better measure of undernutrition in neonates. This finding may explain why low BF% is associated with an increased risk of serious morbidities in the first year of life. However, further studies are needed to confirm whether BF% is superior to birth weight percentiles in identifying at-risk populations. Our results support the need for early detection of underweight infants who require nutritional interventions to reduce their risk of developing long-term health problems. If confirmed, BF% could become an important screening tool for neonatal undernutrition in clinical practice. Further work is required to determine whether BF% should replace or supplement current measures of growth, which are based on birth weight alone. Such findings would have significant implications for public health policy and resource allocation. In summary, our data suggest that BF% may be a better indicator of undernutrition than birth weight percentiles. Future investigations will help to establish its validity and applicability in routine clinical care.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The assistant's response correctly interprets the study's main finding that neonatal BF% is more strongly associated with neonatal morbidity than birth weight percentiles and appropriately uses cautious language (suggesting BF% could be a better measure and that further studies are needed). However, it contains minor inaccuracies/overstatements: it refers to "the first year of life" whereas the study measured neonatal morbidity (early neonatal period), and it uses phrasing ("Our results") that may imply authorship. The answer also could have been improved by explicitly noting that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk, and by citing the reported effect sizes. Overall the response is accurate and appropriately cautious despite these small issues.

conciseness: 0.6
Reasoning:
The assistant's reply correctly concludes that BF% appears to be a better indicator than birth weight percentiles and cites uncertainty/future research needs. However, it is wordy and repetitive—repeating similar caveats and implications—so it could be much more concise while preserving the main conclusion and a single brief caveat about needing further validation.

relevance: 0.8
Reasoning:
The assistant's reply is relevant and directly answers the question: it states that BF% appears to be a better measure because it is more strongly associated with neonatal morbidity than birth weight percentiles, which mirrors the study's key finding. It correctly notes uncertainty and the need for further research. Minor shortcomings: it does not quote the study verbatim or cite the reported effect sizes (ORs), and it introduces a detail ("first year of life") not present in the provided context. Overall, the response is on-topic and grounded in the study's conclusions but could be improved by citing the exact results and avoiding the slight unsupported phrasing.

coherence: 0.9
Reasoning:
The response is generally coherent and well organized: it restates the study's main finding (BF% more strongly associated with neonatal morbidity than birth weight percentiles), draws a cautious conclusion that BF% may be a better measure, and appropriately notes the need for further research and consideration of clinical implementation. Minor issues reduce clarity slightly — it repeats similar points, and it mentions "the first year of life" (which extends beyond the neonatal period reported) rather than sticking to the neonatal timeframe; it also could have strengthened the argument by citing the reported effect sizes. Overall the answer is clear, logically structured, and appropriately cautious.

helpfulness: 0.7
Reasoning:
The assistant's answer correctly concludes that BF% appears to be a better indicator of undernutrition-associated neonatal morbidity than birth-weight percentiles and appropriately notes the need for further study and potential clinical/public-health implications. It is concise and cautious. However, it omits key specifics from the study (eg, effect sizes/ORs, prevalence figures such as 73 per 1,000 identified by low BF%), slightly overstates the timeframe by mentioning "first year of life" when the study assessed neonatal morbidity, and uses language ("our results") that could imply the assistant/answer authored the study. Including the numeric results and the study's specific claim that BF% can identify appropriately grown yet undernourished neonates (and exclude small neonates not at risk) would make the response more informative and accurate.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The endovascular revascularization procedure can be used as an alternative to open bypass grafting and is recommended when there is severe peripheral arterial disease or when the patient cannot tolerate open surgery. The aim of endovascular treatment is to restore blood flow to the affected tissues. Surgical debridement may also be necessary to remove necrotic tissue and bacteria from the wound. However, the use of endovascular revascularization in the management of Ischemic Charcot foot is still controversial and requires further investigation. Furthermore, the duration of treatment is variable depending on the severity of the disease, but it usually takes about three months before the wounds are fully healed. The presence of ulceration, osteomyelitis, or arthritis should be considered in the decision making process for surgical intervention. Therefore, it is important to consider these factors in the choice of therapy. It is always recommended to consult a specialist for more information.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.3
Reasoning:
The assistant's reply includes some correct points (endovascular revascularization can restore blood flow and may be used instead of open bypass in selected patients; wound debridement and consideration of infection/osteomyelitis are important). However it fails to directly answer the question that ischemic Charcot foot is not a completely different disease but rather Charcot neuroarthropathy complicated by critical limb ischemia, which typically requires revascularization in addition to usual surgical/orthopedic care to achieve limb salvage. The answer is misleading in calling revascularization “still controversial” (the presented data support its necessity to enable limb- and foot-salvage) and gives an incorrect/optimistic typical healing time (“about three months”) versus the reported mean ~197 days. Overall the reply is partially correct but incomplete and contains inaccurate or misleading claims.

conciseness: 0.3
Reasoning:
The response is not concise: it wanders through procedural details, an unsupported claim that the approach is “controversial,” and an unnecessary recommendation to consult a specialist, rather than directly answering whether ischemic Charcot foot represents a different entity requiring revascularization plus surgical/orthopedic treatment. It includes extra, potentially inaccurate timing detail and omits the clear, focused conclusion the question seeks.

relevance: 0.3
Reasoning:
The assistant’s reply addresses the general management of ischemic Charcot foot (noting revascularization and debridement) but fails to reference or quote the provided study data. It omits the study’s key results (90% limb salvage, mean healing time ~197 days) and gives an inaccurate healing-time claim (“about three months”) that conflicts with the context. The answer is therefore only partially relevant to the question as framed by the supplied clinical data and does not use a real quote from the context.

coherence: 0.5
Reasoning:
The response is generally organized and addresses relevant topics (revascularization, debridement, wound-healing factors, and uncertainty in the literature), so it reads coherently. However it fails to directly answer the posed question ("Is ischemic Charcot foot a different disease requiring different treatment?"), makes some overgeneralized or imprecise statements (e.g., recommending endovascular therapy “when there is severe PAD” without nuance, and stating wounds usually heal in about three months, which conflicts with the study’s mean ~197 days), and omits study-specific outcomes (limb-salvage rate) that are central to the clinical question. Overall the structure is clear but the answer is incomplete and contains inaccuracies.

helpfulness: 0.4
Reasoning:
Explanation: The assistant's reply gives some relevant, general points (endovascular revascularization as an alternative to open bypass, role of debridement, need to consider ulceration/osteomyelitis), but it also contains important shortcomings relative to the provided ground truth and study data. It inaccurately frames revascularization as merely "controversial" rather than presenting that revascularization is necessary to enable surgical/orthopedic treatment and can lead to limb salvage (the study showed a 90% limb-salvage rate). It also understates healing time (states "about three months" versus the reported mean ~197 days) and fails to report the study outcomes. Overall the answer is partially helpful but imprecise and somewhat misleading for this context.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Radical hysterectomy is not necessary for all patients with endometrial cancer and suspected cervical involvement. This recommendation is based on the results of the Gynecologic Oncology Trial and Investigation Consortium of North Kanto Study (GOTIC) in which 300 patients with endometrial cancer and suspected cervical involvement underwent different types of surgery. In this study, no difference was found in terms of overall survival, progression-free survival or complications of the surgery when comparing patients undergoing radical hysterectomy to those undergoing modified radical hysterectomy or simple hysterectomy. This suggests that less invasive procedures may be sufficient for patients with suspected cervical involvement. Further studies should be conducted to validate these findings and determine if they apply to other patient populations. As always, the best course of action is to consult with a qualified healthcare professional regarding individual treatment plans.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.5
Reasoning:
Short explanation:
The assistant correctly reports the GOTIC study's main finding that radical hysterectomy did not improve overall survival or progression‑free survival compared with modified radical or simple hysterectomy and appropriately notes the need for further study. However, it incorrectly states there was no difference in surgical complications; the ground truth specifies that radical hysterectomy was associated with longer operative time, higher transfusion rates, and more severe urinary tract dysfunction (more perioperative and late adverse events). The answer also slightly overgeneralizes by saying RH is "not necessary for all patients" without qualifying that the study was retrospective and that treatment decisions require individual clinical judgment.

conciseness: 0.8
Reasoning:
The assistant's reply is concise and directly answers the question, summarizing the GOTIC study's main conclusion that radical hysterectomy offers no clear survival benefit and that less invasive procedures may suffice. However, it inaccurately states there were "no differences" in complications — the study actually reported more perioperative and late adverse events (longer operative time, higher transfusion rates, more severe urinary dysfunction) with radical hysterectomy. Overall brevity and focus are good but the factual error about complications is a notable flaw.

relevance: 0.4
Reasoning:
The assistant's reply is relevant and cites the GOTIC study, so it answers the question. However it inaccurately states there were "no differences ... in complications" between radical and less‑radical hysterectomies. The study actually found more perioperative and late adverse events (longer operative time, higher transfusion rates, more severe urinary dysfunction) with radical hysterectomy, while finding no survival benefit. The assistant also slightly overgeneralizes by saying RH is "not necessary for all patients" without noting that decisions should be individualized and that prospective studies are needed.

coherence: 0.4
Reasoning:
The response is generally coherent and concise and correctly conveys that the GOTIC study found no survival benefit from radical hysterectomy (RH) compared with less extensive procedures. However it includes a factual error and omits important study findings: the assistant incorrectly states there was no difference in complications between RH and other procedures, whereas the study reported higher perioperative and late adverse events with RH. It also omits that age, grade, peritoneal cytology, and lymph node status were identified as prognostic factors and that type of hysterectomy was not an independent prognostic factor. Because of these inaccuracies and omissions the answer is misleading despite overall clarity.

helpfulness: 0.6
Reasoning:
The assistant's reply is concise and cites the GOTIC study, correctly noting no survival benefit from radical hysterectomy and recommending further research and individualized clinical decision-making. However, it inaccurately states there were "no differences ... in ... complications" — the study actually found more perioperative and late adverse events (longer operative time, higher transfusion rates, worse urinary dysfunction) with radical hysterectomy. The assistant also somewhat overstates the conclusion ("not necessary for all patients") instead of emphasizing the study's retrospective design and the need for cautious interpretation.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD might be a useful indicator of quality care. However, it should be considered as part of the overall quality metrics of surgical care. This study highlights the need for better patient selection and more careful perioperative management. Pancreatic fistulas and multivisceral resections may require specialized treatment to reduce the risk of readmission. Future studies could focus on identifying additional predictors and potential interventions. It is also important to note that these results reflect a single institution experience and should be validated by other institutions. Furthermore, readmissions may be related to comorbidities and other medical conditions, which may also affect the outcome of the operation. These findings underscore the importance of close monitoring of patients and early detection of any complications. Proper treatment of readmissions may help improve outcomes and reduce unnecessary costs. This information will allow us to develop strategies to avoid readmissions or identify and treat complications earlier. Further investigation into the factors contributing to readmissions will enhance our understanding of their prevention. Ultimately, this knowledge will contribute to improving the quality of care and patient outcomes following PD. The results suggest that patients who had a multivisceral resection at the time of PD have an increased risk of readmission. However, there are no specific biochemical markers that are predictive of readmissions. Therefore, multivisceral resection must be carefully planned and executed, and the patient's postoperative course must be closely monitored. If a pancreatic fistula occurs, it is essential to treat it promptly to minimize the risk of readmission. Delayed gastric emptying and pneumonia are more likely to occur immediately after surgery. In addition, failure to thrive and intra-abdominal hemorrhage may lead to readmissions later on. It is essential to maintain a close relationship with the patient and provide adequate support during the early postoperative period. Future studies should investigate whether changes in perioperative management, such as reducing the use of general anesthesia, optimizing bowel preparation, or enhancing the level of intensive care, would result in fewer readmissions. Moreover, further investigations into the cost-effectiveness of these strategies are needed. Overall, readmissions after PD are complex and multifactorial. To address this problem, we must combine efforts to improve patient selection and perioperative management. By doing so, we can decrease the likelihood of readmissions, improve patient outcomes, and ultimately reduce health care costs. The high rate of readmissions after PD suggests that we must pay more attention to the factors that contribute to this phenomenon. Identifying these factors will help us develop strategies to reduce readmissions. The development of evidence-based guidelines for PD surgery requires further evaluation. Future research should focus on the role of these factors in determining the likelihood of readmission. These findings will inform the development of guidelines for preventing readmissions. The impact of readmissions on health-care expenses needs to be assessed. This will help us understand the economic benefits of implementing strategies to reduce readmissions. We recommend that surgeons and patients take steps to minimize the risk of readmission. These steps include selecting patients appropriately, performing meticulous preoperative planning, and providing intensive postoperative care. We propose that all centers interested in improving the quality

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The assistant correctly notes key findings from the study—pancreatic fistula and more complex (multivisceral) initial resections were independently associated with readmission, there were no predictive biochemical markers reported, and early (≤7 days) vs late (>7 days) causes differed. It also appropriately cautions about single‑institution data and emphasizes close monitoring and prompt treatment of complications.

However, the reply has weaknesses: it fails to highlight the study's important quantitative point that about half of readmissions occur within 7 days and therefore that prevention efforts should particularly target early readmissions; it offers several speculative or unsupported interventions (e.g., reducing use of general anesthesia, changing bowel prep) not grounded in the presented data; and it is long and repetitive without providing concise, evidence‑based prevention priorities.

conciseness: 0.2
Reasoning:
The response is verbose and repetitive, offering many generic recommendations rather than a concise summary of the study's key findings. It does mention pancreatic fistula and multivisceral resection as risk factors, but it fails to clearly state that these were independent predictors and omits the important, concise takeaway that half of readmissions occur within 7 days and that preventing early readmissions should be a priority. Overall it is not concise or to the point.

relevance: 0.7
Reasoning:
The assistant's reply is largely relevant: it cites real findings from the provided context (pancreatic fistula and multivisceral resection as risk factors, lack of predictive biochemical markers, differences between early and late readmission causes, and the single-institution limitation) and uses those to answer whether readmissions can be prevented. However the response is verbose and repetitive, omits some specific independently associated predictors reported in the context (for example length of initial stay >7 days and ICU admission), and does not explicitly state the key quantified finding that half of readmissions occur within 7 days. For those reasons the answer is accurate in content and relevant but not concise or fully comprehensive.

coherence: 0.6
Reasoning:
The assistant's reply is generally coherent and organized: it summarizes risk factors (pancreatic fistula, multivisceral resection), suggests plausible prevention approaches (patient selection, perioperative care, close monitoring), and calls for validation and further study. However it is overly generic and repetitive, misses the important emphasized finding that half of readmissions occur within 7 days (so preventing early readmissions should be a priority), and the answer trails off abruptly—reducing clarity and completeness. 

helpfulness: 0.5
Reasoning:
Short explanation: The response correctly identifies some key associations (pancreatic fistula, multivisceral resection) and notes that early and late readmissions have different causes, which is useful. However it is overly long and repetitive, does not emphasize the most actionable finding from the study — that half of readmissions occur within 7 days and efforts should prioritize preventing early readmissions — and it introduces speculative or unsupported interventions (e.g., reducing general anesthesia, bowel preparation) without evidence. It also omits key quantified results (15% readmission rate, ORs) that would help interpret magnitude. Overall, partially helpful but unfocused and lacking the clear, evidence-based takeaways needed for practice or policy.

================================================================================
Average correctness Score: 0.49
Average conciseness Score: 0.445
Average relevance Score: 0.525
Average coherence Score: 0.555
Average helpfulness Score: 0.485
